Thermostable RNA Polymerase Variant for Co-transcriptional Capping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for co-transcriptional capping of RNA during in vitro transcription are inefficient, resulting in a mixture of capped and uncapped products, with existing solutions either decreasing reaction efficiency or requiring additional enzymatic steps, making it challenging to produce homogenously capped RNA.
Innovation Solution
A method involving a thermostable RNA polymerase variant with specific amino acid substitutions and a cap analog, such as m7G trinucleotide, is used to achieve nearly 100% capping efficiency during co-transcriptional capping, eliminating the need for post-transcriptional enzymatic steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a cap analog is used in co-transcriptional capping, then capping can be achieved during transcription, but the cap analogue competes with GTP as initiator nucleotide resulting in mixed capped and uncapped products
Solution Approach 1:
The patent changes the chemical parameters of the cap analog by introducing a 3'-O-alkyl group (where alkyl is methyl, ethyl, propyl, or butyl) at the 3' position of the cap structure. This structural modification alters the competition dynamics between the cap analog and GTP, enabling selective incorporation of the cap analog without significant competition from GTP, thereby producing homogeneously capped RNA products.
Solution Approach 2:
The patent employs a modified cap analog that functions as a temporary initiator during transcription but is subsequently removed or ignored by the transcription system. The 3'-O-alkyl group modification allows the cap analog to initiate transcription effectively while avoiding permanent competition with GTP, effectively making the cap analog a disposable initiator that achieves its purpose without creating lasting competitive interference.
2Manufacturing precision
If GTP concentration is lowered to reduce competition, then cap analog incorporation increases, but overall reaction efficiency decreases
Solution Approach 1:
Instead of changing the concentration parameter (lowering GTP), the patent changes the structural parameter of the cap analog by adding a 3'-O-alkyl group. This structural modification inherently reduces competition with GTP, allowing standard GTP concentrations to be maintained while achieving homogeneous capping, thus preserving reaction efficiency.
3Manufacturing precision
If phosphatase treatment is used to remove uncapped RNA, then capping purity increases, but additional enzymatic steps are required
Solution Approach 1:
The patent applies preliminary action by incorporating the modified cap analog directly during the transcription process itself. The 3'-O-alkyl group modification ensures that the cap analog is selectively incorporated without significant competition from GTP, producing homogeneously capped RNA from the start. This eliminates the need for subsequent phosphatase treatment steps to remove uncapped products.
4Productivity
If conventional T7 RNA polymerase is used, then transcription can proceed, but capping efficiency is limited due to competition with GTP
Solution Approach 1:
The patent changes the chemical parameter of the cap analog by introducing a 3'-O-alkyl group (methyl, ethyl, propyl, or butyl). This structural modification fundamentally alters the interaction with T7 RNA polymerase, reducing competition with GTP and enabling efficient cap analog incorporation while maintaining high transcription rates with conventional polymerases.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach ensures high capping efficiency, producing almost entirely capped RNA transcripts, as demonstrated by liquid chromatography-mass spectrometry analyses, regardless of temperature or promoter sequences, thereby simplifying the production of homogenously capped RNA.
Implementation Method 1
RNA synthesized via in vitro transcription (IVT) can be capped during the transcription reaction (in a process called 'co-transcriptional capping')
Implementation Method 2
digesting uncapped (i.e., triphosphorylated) RNA with a phosphatase which dephosphorylates the 5′ end of the RNA
Data Source
AI summary
Methods and compositions for capping RNA in an in vitro transcription mixture are provided that include a thermostable RNA polymerase variant and a cap analog such that when a DNA template is added to the mixture, and the mixture is then incubated under conditions for in vitro transcription, capped RNA is produced.